Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats

Neuropharmacology

Volumn 58, Issue 1, 2010, Pages 38-43

  Carson, Dean S ^a   Cornish, Jennifer L ^b   Guastella, Adam J ^a   Hunt, Glenn E ^a   McGregor, Iain S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

Hyperactivity; Methamphetamine; Neuropeptide; Oxytocin; Reinforcement; Self administration

Indexed keywords

METHAMPHETAMINE; OXYTOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG SELF ADMINISTRATION; HABITUATION; HYPERACTIVITY; MALE; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; RELAPSE;

AMPHETAMINE-RELATED DISORDERS; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; OXYTOCICS; OXYTOCIN; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION;

EID: 71549163431     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.06.018     Document Type: Article

References (40)

1. Aragona B.J., Liu Y., Yu Y.J., Curtis J.T., Detwiler J.M., Insel T.R., and Wang Z. Nucleus accumbens dopamine differentially mediates the formation and maintenance of monogamous pair bonds. Nature Neuroscience 9 (2006) 133-139
2. Bales K.L., van Westerhuyzen J.A., Lewis-Reese A.D., Grotte N.D., Lanter J.A., and Carter C.S. Oxytocin has dose-dependent developmental effects on pair-bonding and alloparental care in female prairie voles. Hormones & Behavior 52 (2007) 274-279
3. Chiodo K.A., Lack C.M., and Roberts D.C. Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats. Psychopharmacology 200 (2008) 465-473
4. Clemens K.J., Cornish J.L., Hunt G.E., and McGregor I.S. Intravenous methamphetamine self-administration in rats: effects of intravenous or intraperitoneal MDMA co-administration. Pharmacology, Biochemistry & Behavior 85 (2006) 454-463
5. Cui S.S., Bowen R.C., Gu G.B., Hannesson D.K., Yu P.H., and Zhang X. Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activation. Journal of Neuroscience 21 (2001) 9867-9876
6. Davidson C., Gopalan R., Ahn C., Chen Q., Mannelli P., Patkar A.A., Weese G.D., Lee T.H., and Ellinwood E.H. Reduction in methamphetamine induced sensitization and reinstatement after combined pergolide plus ondansetron treatment during withdrawal. European Journal of Pharmacology 565 (2007) 113-118
7. Deroche-Gamonet V., Belin D., and Piazza P.V. Evidence for addiction-like behavior in the rat. Science 305 (2004) 1014-1017
8. Domes G., Heinrichs M., Glascher J., Buchel C., Braus D.F., and Herpertz S.C. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biological Psychiatry 62 (2007) 1187-1190
9. Donaldson Z.R., and Young L.J. Oxytocin, vasopressin, and the neurogenetics of sociality. Science 322 (2008) 900-904
10. Ferrucci M., Pasquali L., Paparelli A., Ruggieri S., and Fornai F. Pathways of methamphetamine toxicity. Annals of the New York Academy of Sciences 1139 (2008) 177-185
11. Gimpl G., and Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiological Reviews 81 (2001) 629-683
12. Guastella A.J., Howard A.L., Dadds M.R., Mitchell P.B., and Carson D.S. A randomized controlled trial of intranasal oxytocin to augment exposure therapy for social anxiety disorder. Psychoneuroendocrinology 34 (2009) 917-923
13. Guastella A.J., Mitchell P.B., and Dadds M.R. Oxytocin increases gaze to the eye region of human faces. Biological Psychiatry 63 (2008) 3-5
14. Guastella A.J., Mitchell P.B., and Mathews F. Oxytocin enhances the encoding of positive social memories in humans. Biological Psychiatry 64 (2008) 256-258
15. Hall D.A., Stanis J.J., Marquez Avila H., and Gulley J.M. A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior. Psychopharmacology 195 (2008) 469-478
16. Heinrichs M., and Domes G. Neuropeptides and social behaviour: effects of oxytocin and vasopressin in humans. Progress in Brain Research 170 (2008) 337-350
17. Koob G.F. Neuroadaptive mechanisms of addiction: studies on the extended amygdala. European Neuropsychopharmacology 13 (2003) 442-452
18. Koob G.F., and Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science 242 (1988) 715-723
19. Kosfeld M., Heinrichs M., Zak P.J., Fischbacher U., and Fehr E. Oxytocin increases trust in humans. Nature 435 (2005) 673-676
20. Kovacs G.L., Izbeki F., Horvath Z., and Telegdy G. Effects of oxytocin and a derivative (Z-prolyl-D-leucine) on morphine tolerance/withdrawal are mediated by the limbic system. Behavioral Brain Research 14 (1984) 1-8
21. Kovacs G.L., Sarnyai Z., Barbarczi E., Szabo G., and Telegdy G. The role of oxytocin-dopamine interactions in cocaine-induced locomotor hyperactivity. Neuropharmacology 29 (1990) 365-368
22. Kovacs G.L., Sarnyai Z., and Szabo G. Oxytocin and addiction: a review. Psychoneuroendocrinology 23 (1998) 945-962
23. Kovacs G.L., and Telegdy G. Beta-endorphin tolerance is inhibited by oxytocin. Pharmacology, Biochemistry & Behavior 26 (1987) 57-60
24. Kovacs G.L., and Van Ree J.M. Behaviourally active oxytocin fragments simultaneously attenuate heroin self-administration and tolerance in rats. Life Sciences 37 (1985) 1895-1900
25. Kramer K.M., Cushing B.S., and Carter C.S. Developmental effects of oxytocin on stress response: single versus repeated exposure. Physiology & Behavior 79 (2003) 775-782
26. Landgraf R., Ermisch A., and Hess J. Indications for a brain uptake of labelled vasopressin and ocytocin and the problem of the blood-brain barrier. Endokrinologie 73 (1979) 77-81
27. McGregor I.S., Callaghan P.D., and Hunt G.E. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?. British Journal of Pharmacology 154 (2008) 358-368
28. Qi J., Yang J.-Y., Wang F., Zhao Y.-N., Song M., and Wu C.-F. Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology 56 (2009) 856-865
29. Qi J., Yang J.Y., Song M., Li Y., Wang F., and Wu C.F. Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice. Naunyn-Schmiedebergs Archives of Pharmacology 376 (2008) 441-448
30. Robinson T.E. Neuroscience. Addicted rats. Science 305 (2004) 951-953
31. Rogers J.L., De Santis S., and See R.E. Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats. Psychopharmacology 199 (2008) 615-624
32. Rose M.E., and Grant J.E. Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Annals of Clinical Psychiatry 20 (2008) 145-155
33. Sarnyai Z., Babarczy E., Krivan M., Szabo G., Kovacs G.L., Barth T., and Telegdy G. Selective attenuation of cocaine-induced stereotyped behaviour by oxytocin: putative role of basal forebrain target sites. Neuropeptides 19 (1991) 51-56
34. Shepard J.D., Chuang D.T., Shaham Y., and Morales M. Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat. Psychopharmacology 185 (2006) 505-513
35. Simon S.L., Dacey J., Glynn S., Rawson R., and Ling W. The effect of relapse on cognition in abstinent methamphetamine abusers. Journal of Substance Abuse Treatment 27 (2004) 59-66
36. Szabo G., Kovacs G.L., and Telegdy G. Effects of neurohypophyseal peptide hormones on alcohol dependence and withdrawal. Alcohol & Alcoholism 22 (1987) 71-74
37. Ujike H., Akiyama K., Nishikawa H., Onoue T., and Otsuki S. Lasting increase in D1 dopamine receptors in the lateral part of the substantia nigra pars reticulata after subchronic methamphetamine administration. Brain Research 540 (1991) 159-163
38. Uvnas-Moberg K., Ahlenius S., Hillegaart V., and Alster P. High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacology, Biochemistry & Behavior 49 (1994) 101-106
39. Van Abeelen J.H., Van der Kroon P.H., and Bekkers M.F. Mice selected for rearing behavior: some physiological variables. Behavior Genetics 3 (1973) 85-90
40. Young L.J., and Wang Z. The neurobiology of pair bonding. Nature Neuroscience 7 (2004) 1048-1054